Neonatal Abstinence Syndrome
Attributes to meet: PDF: Download File, Fact Sheets
Download File: condition met
Fact Sheet, 2020
Neonatal abstinence syndrome (NAS) is a condition whereby infants who are exposed to particular substances in the womb experience a variety of withdrawal symptoms shortly after they are born. This fact sheet shares information about the signs and symptoms of NAS, treatment, at-home care recommendations, and potential long-term outcomes.
Related products
-
Late Preterm Infant (Near-Term)
Fact Sheet, 2023
A late preterm infant is a baby that is born between 34-36 (almost 37) weeks of pregnancy. This fact sheet provides information about some health problems that might affect a late preterm infant, things that caregivers and parents should watch for, and some questions to be discussed before leaving the hospital.
SKU: 2-201 -
Neonatal Abstinence Syndrome Literature Review
Report, 2020
Neonatal abstinence syndrome (NAS) is a condition whereby some infants exposed to particular substances in utero experience a variety of postnatal withdrawal symptoms shortly after birth. Increased rates of NAS have been reported in Canada over the past decade. This review provides information about the development and effects of NAS, modes of assessment, treatment options (both pharmacological and non-pharmacological), care guidelines for parents and caregivers, and primary prevention strategies.
SKU: 2-905 -
Infant Mortality in Saskatchewan: Evidence to Inform Public Health Practice
Report, 2009
This document was prepared to describe the relationship between modifiable risk factors and infant mortality. It is meant to provide guidance, strategies, and support to help expand or develop programs that may contribute to the reduction of infant mortality in Saskatchewan. It includes a review of the literature regarding prevalent risk factors associated with infant mortality, as well as identifying promising practices related to those modifiable risk factors.
SKU: 2-457 -
Safe Sleep Evidence Summary
Report, 2017
This evidence summary summarizes evidence based guidelines on safe sleep and is intended for use by policy makers, healthcare providers, and service providers.
SKU: 2-438